DrugDashboards

Market view

phendimetrazine tartrate · Powder

2 marketed package NDCs · 2 active manufacturers

Most dispensed: 35 mg · Tablet · #1000 tablets/bottle · 35 mg · Tablet · #100 tablets/bottle · 105 mg · Capsule, Extended Release · #30 capsule, extended releases/bottle · 35 mg · Tablet · #30 tablets/bottle

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

What changed in the last 90 days

Every detected change for phendimetrazine tartrate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Sympathomimetic Amine Anorectic, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Phendimetrazine tartrate in shortage right now?
No. FDA does not currently list Phendimetrazine tartrate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Phendimetrazine tartrate?
14 companies have marketed Phendimetrazine tartrate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Phendimetrazine tartrate cost?
The typical pharmacy pays about $0.1328 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.